Export traceability requirements for pharmaceuticals require barcode-based track-and-trace and certificates of analysis to prevent counterfeit exports. Export shipments of drugs and pharmaceuticals under the Drugs & Cosmetics Act must include, at shipment, a Certificate of Analysis issued by the manufacturer, by an importing-country/FDA-approved laboratory, or by a laboratory approved by the Drugs Controller; port drug control officials may retain consignment samples for reference and tracing. Exporters must implement GS1 barcode-based track-and-trace across primary, secondary and tertiary packaging encoding GTIN, batch number, expiry date and serial number.
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Export traceability requirements for pharmaceuticals require barcode-based track-and-trace and certificates of analysis to prevent counterfeit exports.
Export shipments of drugs and pharmaceuticals under the Drugs & Cosmetics Act must include, at shipment, a Certificate of Analysis issued by the manufacturer, by an importing-country/FDA-approved laboratory, or by a laboratory approved by the Drugs Controller; port drug control officials may retain consignment samples for reference and tracing. Exporters must implement GS1 barcode-based track-and-trace across primary, secondary and tertiary packaging encoding GTIN, batch number, expiry date and serial number.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.
TaxTMI 
of 
TaxTMI 
